The latest market report published by Credence Research, Inc. “Global Subdermal Contraceptive Implants’ Market: Growth, Prospects, and Competitive Analysis, 2016 – 2030“. The global Subdermal Contraceptive Implants’ Market generated revenue of around USD 846.9 million in 2022 and is anticipated to grow a CAGR of over 3.30% during the forecast period from 2023 to 2030 to reach around USD 1029.04 million in 2030.
Subdermal contraceptive implants are small matchstick-sized plastic rods inserted under the upper arm’s skin. This process is usually carried on with the help of local anesthesia. Once implanted, the rod releases an etonogestrel hormone at an average rate of 50 mcg/day for nearly three to five years. The primary growth drivers in the global subdermal contraceptive market are rising disposable income, increased awareness regarding contraceptives, and technological advancements. Additionally, supportive government schemes in the field and rising demand for contraceptives owing to increasing abortions will fuel the incremental market growth during the forecast period.
The global subdermal contraceptive implants market is bifurcated into Type, Application, and Geography. Based on type, the market is categorized into etonogestrel implants, levonorgestrel implants, and others. Based on application, the market can be categorized into hospitals, clinics, and research facilities. The market is segmented based on geography: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
In 2021, North America occupied the largest subdermal therapeutics implants market during the forecast period. Factors such as the presence of a well-developed infrastructure, increasing prevalence of sexually transmitted diseases, and rising healthcare expenditure are expected to increase the market’s footprint in the region. Also, improving technological advancements and rising research and development investments will support a sustainable market during the forecast period. The United States is expected to contribute most of the share in terms of revenue for the North American region. Factors such as the increasing number of supportive government policies and potential abortions will add to the substantial growth of the market in the country.
The contraceptive implant is a small, rod-shaped device that is inserted under the skin of the upper arm. It releases a hormone called etonogestrel, which prevents pregnancy. The implant is a long-acting, reversible method of contraception that is ideal for women who do not want to have to think about contraception on a daily basis.
Subdermal contraceptive implants are currently one of the most popular methods of contraception, with millions of women around the world using them. The market for these devices is currently growing rapidly, as more and more women are looking for safe and effective methods of contraception.
Why to Buy This Report-
- The report provides a qualitative and quantitative analysis of the global subdermal contraceptive implants by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2017-2021, base year- 2022, and forecast period 2023-2030.
- The report contains information related to the competitive landscape, like how the key players in the market are operating at a global, regional, and country level.
- In-depth analysis of the global subdermal contraceptive implants segmentation based on type, application, and regional integration.
- The global subdermal contraceptive implants report also includes analysing the global, regional, and country levels, key market trends, significant players analysis, market growth strategies, and key application areas.
Browse Full Report: https://www.credenceresearch.com/report/subdermal-contraceptive-implants-market